Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
03. Januar 2019 02:30 ET
|
Curium
Paris, France and St. Louis, MO USA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Curium, a leading global player in Nuclear medicine, and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company...